BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15507770)

  • 1. The influence of autoantibodies to myeloperoxidase on neutrophil function and intracellular signaling.
    Williams J; Hewins P; Savage C
    Jpn J Infect Dis; 2004 Oct; 57(5):S5-6. PubMed ID: 15507770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of myeloperoxidase in vasculitis development.
    Suzuki K; Okazaki T
    Jpn J Infect Dis; 2004 Oct; 57(5):S2-3. PubMed ID: 15507759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical features and pathology of vasculitis associated with anti-myeloperoxidase autoantibodies.
    Jayne D
    Jpn J Infect Dis; 2004 Oct; 57(5):S16-7. PubMed ID: 15507756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies.
    Brachemi S; Mambole A; Fakhouri F; Mouthon L; Guillevin L; Lesavre P; Halbwachs-Mecarelli L
    J Am Soc Nephrol; 2007 Aug; 18(8):2330-9. PubMed ID: 17634439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An IgM class anti-neutrophil cytoplasm antibody inhibits neutrophil adhesion and apoptosis via a Syk dependent signaling cascade.
    Hayes MJ; Cambridge G
    Mol Immunol; 2004 Jun; 41(4):457-68. PubMed ID: 15163542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A; Xiao H; Falk RJ; Jennette JC
    J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing on formalin-fixed neutrophils is less sensitive and specific for small vessel vasculitis, and less sensitive for MPO-ANCA, than most ELISAs.
    Pollock W; Trevisin M; Savige J;
    J Immunol Methods; 2008 Dec; 339(2):141-5. PubMed ID: 18823991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner.
    Hoshino A; Nagao T; Nagi-Miura N; Ohno N; Yasuhara M; Yamamoto K; Nakayama T; Suzuki K
    J Autoimmun; 2008 Aug; 31(1):79-89. PubMed ID: 18501296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotype antibodies to anti-myeloperoxidase autoantibodies in patients with systemic vasculitis.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):221-6. PubMed ID: 8388692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloperoxidase specific anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA).
    Falk RJ; Hogan SL; Wilkman AS; Terrell RS; Lauritzen S; Charles LA; Jennette JC
    Neth J Med; 1990 Apr; 36(3-4):121-5. PubMed ID: 2162486
    [No Abstract]   [Full Text] [Related]  

  • 12. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jennette JC; Falk RJ
    Curr Opin Rheumatol; 2008 Jan; 20(1):55-60. PubMed ID: 18281858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic role of anti-neutrophil cytoplasmic antibodies in vasculitis.
    Pankhurst T; Savage CO
    Curr Opin Pharmacol; 2006 Apr; 6(2):190-6. PubMed ID: 16483847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?
    Heeringa P; Huugen D; Tervaert JW
    Trends Immunol; 2005 Nov; 26(11):561-4. PubMed ID: 16139567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo?
    Bosch X; Guilabert A; Espinosa G; Mirapeix E
    Trends Immunol; 2008 Jun; 29(6):280-9. PubMed ID: 18440274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and disease associated anti-myeloperoxidase (MPO) autoantibodies.
    Guilpain P; Servettaz A; Batteux F; Guillevin L; Mouthon L
    Autoimmun Rev; 2008 Jun; 7(6):421-5. PubMed ID: 18558355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.
    Hu N; Westra J; Huitema MG; Bijl M; Brouwer E; Stegeman CA; Heeringa P; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2009 May; 60(5):1548-57. PubMed ID: 19404956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
    Vermeersch P; Vervaeke S; Blockmans D; van Hoovels L; Mariƫn G; Vanmaele H; Bossuyt X
    Clin Chim Acta; 2008 Nov; 397(1-2):77-81. PubMed ID: 18708041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
    Gao Y; Ye H; Yu F; Guo XH; Zhao MH
    Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope-specific anti-neutrophil cytoplasmic antibodies: do they matter? Can they be detected?
    Specks U
    APMIS Suppl; 2009 Jun; (127):63-6. PubMed ID: 19515143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.